温经活血通络方外用治疗白蛋白紫杉醇所致阳虚血瘀型周围神经病变的临床研究OA
Clinical study on the external application of Wenjing Huoxue Tongluo Formula in the treatment of oxaliplatin-induced peripheral neuropathy caused by albumin paclitaxel with yang deficiency and blood stasis type
目的 探讨温经活血通络方外用治疗白蛋白紫杉醇所致阳虚血瘀型周围神经病变(OIPN)的效果.方法 选取 2022 年 6 月至 2023 年 8 月醴陵市中医院由白蛋白紫杉醇化疗导致OIPN且中医辨证符合阳虚血瘀型的患者 60 例为研究对象,采用随机数表法将其分为对照组(n=30,予以甲钴胺胶囊治疗)和治疗组(n=30,予以甲钴胺胶囊+温经活血通络方治疗),两组均治疗 14 d.评估两组疗效、毒性副反应、中医症候评分和不良反应情况.结果 治疗组总有…查看全部>>
Objective To explore the effect of external application of Wenjing Huoxue Tongluo Formula in the treatment of oxaliplatin-induced peripheral neuropathy(OIPN)caused by albumin paclitaxel with yang deficiency and blood stasis type.Methods A total of 60 patients with OIPN caused by albumin paclitaxel chemotherapy at Liling Hospital of Traditional Chinese Medicine from June 2022 to August 2023 were selected as the study subjects,and their traditional Chinese med…查看全部>>
邓飞龙;易丽莎;谢泽义;李思聪
湖南省醴陵市中医院肿瘤科,湖南醴陵 412200湖南省醴陵市中医院肿瘤科,湖南醴陵 412200湖南省醴陵市中医院肿瘤科,湖南醴陵 412200湖南省醴陵市中医院肿瘤科,湖南醴陵 412200
临床医学
温经活血通络方毒性副反应紫杉醇阳虚血瘀证周围神经病变
Wenjing Huoxue Tongluo FormulaToxic side effectsPaclitaxelYang deficiency and blood stasis syndromeOxaliplatin-induced peripheral neuropathy
《中国医药科学》 2024 (10)
75-78,4
湖南省中医药科研计划项目(D2022080).
评论